1、EntacaponeCat. No.: HY-14280CAS No.: 130929-57-6Molecular Formula: CHNOMolecular Weight: 305.29Target: COMTPathway: Metabolic Enzyme/Protease; Neuronal SignalingStorage: Powder -20C 3 years4C 2 yearsIn solvent -80C 6 months-20C 1 monthSolvent 68(5):589-94.2. Di Giovanni S, Eleuteri S, Paleologou KE,
2、 Entacapone and tolcapone, two catechol O-methyltransferase inhibitors, block fibril formation of alpha-synuclein and beta-amyloid and protect against amyloid-induced toxicity. J Biol Chem. 2010 May 14;285(20):14943. Sethi KD, Hauser RA, Isaacson SH, Levodopa/carbidopa/entacapone 200/50/200 mg (Stal
3、evo 200) in the treatment of Parkinsons disease: a case series. Cases J. 2009 Jul 30;2:7134.4. Poulopoulos M, Waters C. Carbidopa/levodopa/entacapone: the evidence for its place in the treatment of Parkinsons disease. Core Evid. 2010 Jul 27;5:1-10.Caution: Product has not been fully validated for medical applications. For research use only.Tel: 609-228-6898 Fax: 609-228-5909 E-mail: techMedChemEAddress: 1 Deer Park Dr, Suite Q, Monmouth Junction, NJ 08852, USAwww.MedChemE2
